FUJIFILM Healthcare Europe and Ibex Partner to Transform Cancer Diagnostics with AI

FUJIFILM Healthcare Europe and IBEX’s Partnership

Image Credits: FugiFilm

Announcement

FUJIFILM Healthcare Europe, a leading digital pathology software 1, and Ibex Medical Analytics, an AI-powered cancer diagnostics company in pathology, announced a partnership. The partnership will contribute to the cancer diagnosis. The specialization of IBEX and the solution of FUJIFILM will provide access to the users globally to maximize laboratory workflow and minimize turnaround time. This new partnership will analyze the difficulties of pathologists with the increasing number of cancer patients, along with the turnaround time expected from healthcare practitioners. The collaboration leads to a solution to enhance and improve the diagnostic workflow. This will help alleviate the difficulties faced by the pathologists.

Improvement

The Ibex’s AI solution has accelerated productivity by 37% and enhanced reporting. Fujifilm’s Synapse Pathology Solution succeeded in providing digital images for diagnosis within 1.7 hours quicker in comparison to glass slides. Its solution consists of an open platform and vendor-neutral system contributing pathology services to run effectively and efficiently. The integration of pathology and digital solutions with effective communication will bolster growth in the diagnostic market. The collaborative strategy to combine AI with a pathology digital solution will minimize turnaround time for prostate cancer diagnosis by 1.8 days to 9.4 minutes.

Ibex’s AI-powered solution helps in detecting cancer and hundreds of other diagnostics, including several tissue types. This solution will provide clinical-level precision and an improved and enhanced user experience. The solutions have been fetched from the rich dataset, like pathology institutes, along with the support of AI algorithms trained by pathologist experts.

The partnership initiative expects to drive the adoption and execution of this solution globally and promote awareness of this integration.

How Important are Pathologists in the Healthcare Market?

Pathologists play a pivotal role in cancer diagnosis and treatment. The predicted cancer cases are expected to be 35 million by the end of 2050. The pathology services are in rising demand, whereas the number of pathologists is low. The Cancer Research UK learned that the increase of 47% workforce will be needed to meet the predicted cases.

Views and Statements

Head of commercialization at FUJIFILM Healthcare Europe, Marc Newman, said, “The partnership with Ibex will not only accelerate our solutions but also support pathologists to serve enhanced patient care. We believe in innovation, encouraging clinicians and providing excellent diagnosis to improve patient care.”

Chief Commercial Officer at Ibex Medical Analytics, Stuart Shand, said, “Ibex is known for its valuable commitment to enabling access to AI tools for better diagnostic workflow to their customers. This will help provide a timely and appropriate cancer diagnosis to their patients.”